Dow Up0.08% Nasdaq Down0.30%

More On PRL.MI

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Pierrel S.p.A. (PRL.MI)

-Milan
0.70 Down 0.01(1.34%) Sep 19
ProfileGet Profile for:
Pierrel S.p.A.
s.s. Appia 7 bis 46/48
Capua, MI 81043
Italy - Map
Website: http://www.pierrel.it

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

Pierrel S.p.A. provides contract research and manufacturing services to the pharmaceutical and life science industries. The company is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations. It also provides consulting and operational services for the research and development of new molecules and drug products; and consulting services for clinical and regulatory development programs, as well as operational services for the execution of international phase I-IV, late phase, and non-interventional clinical trials. Pierrel S.p.A. has an agreement with Tixupharma for the development and sale of a device to treat periodontitis patients. The company operates in the United States, Australia, Canada, Russia, and the Middle East. Pierrel S.p.A. is based in Capua, Italy.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Pierrel S.p.A.

Key Executives 
 PayExercised
Mr. Raffaele Petrone , 49
Chief Exec. Officer and Director
85.00KN/A
Dr. Henri Kool van Langenberghe Ph.D., 58
Chief Operating Officer
N/AN/A
Mr. Toni Valente , 53
Technical Director
N/AN/A
Dr. Stephan Henauer M.D., 63
Chief Scientific Officer
N/AN/A
Mr. Bernardo Verrengia , 65
Chief Quality Officer
N/AN/A
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in EUR.